• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

OphthaliX Inc

+ Add to Watchlist


0.8500 USD 0.0500 6.25%

As of 20:10:05 ET on 11/25/2014.

Snapshot for OphthaliX Inc (OPLI)

Open: 0.8000 Day's Range: 0.8000 - 0.8500 Volume: 20,525
Previous Close: 0.8000 52wk Range: 0.5000 - 6.1000 1-Yr Rtn: -

Stock Chart for OPLI

No chart data available.
  • OPLI:US 0.8500
  • 1D
  • 1M
  • 1Y
Interactive OPLI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OPLI

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 8.88
Shares Outstanding (M) 10.44
30 Day Average Volume 3,484
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OPLI

No data available

Company Profile & Key Executives for OPLI

OphthaliX Inc. is an advanced clinical-stage biopharmaceutical company focused on drug development for the treatment of ophthalmic diseases. The Company's drug candidate is currently developed for ophthalmic indications including Dry Eye Syndrome(Phase3), Glaucoma (Phase 2) and Uveitis as well as or the treatment of autoimmune inflammatory diseases.

Pnina FishmanChairmanBarak SingerChief Executive Officer
Itay WeinsteinChief Financial OfficerRonen KantorSecretary
More Company Profile & Key Executives for OPLI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil